Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complications of chemotherapy, a basic science update.
Mazevet M, Moulin M, Llach-Martinez A, Chargari C, Deutsch E, Gomez AM, Morel E. Mazevet M, et al. Among authors: morel e. Presse Med. 2013 Sep;42(9 Pt 2):e352-61. doi: 10.1016/j.lpm.2013.06.011. Epub 2013 Aug 22. Presse Med. 2013. PMID: 23972551 Review.
Complications of thoracic radiotherapy.
Chargari C, Riet F, Mazevet M, Morel E, Lepechoux C, Deutsch E. Chargari C, et al. Among authors: morel e. Presse Med. 2013 Sep;42(9 Pt 2):e342-51. doi: 10.1016/j.lpm.2013.06.012. Epub 2013 Aug 22. Presse Med. 2013. PMID: 23972736 Review.
Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis.
Monceau V, Llach A, Azria D, Bridier A, Petit B, Mazevet M, Strup-Perrot C, To TH, Calmels L, Germaini MM, Gourgou S, Fenoglietto P, Bourgier C, Gomez AM, Escoubet B, Dörr W, Haagen J, Deutsch E, Morel E, Vozenin MC. Monceau V, et al. Among authors: morel e. Radiother Oncol. 2014 Apr;111(1):63-71. doi: 10.1016/j.radonc.2014.01.025. Epub 2014 Apr 7. Radiother Oncol. 2014. PMID: 24721545
Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity.
Llach A, Mazevet M, Mateo P, Villejouvert O, Ridoux A, Rucker-Martin C, Ribeiro M, Fischmeister R, Crozatier B, Benitah JP, Morel E, Gómez AM. Llach A, et al. Among authors: morel e. J Mol Cell Cardiol. 2019 Jan;126:129-139. doi: 10.1016/j.yjmcc.2018.11.019. Epub 2018 Nov 28. J Mol Cell Cardiol. 2019. PMID: 30500377
Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M, Berthouze-Duquesnes M, Breckler M, Tortosa F, Fazal L, de Régibus A, Laurent AC, Varin A, Lucas A, Branchereau M, Marck P, Schickel JN, Deloménie C, Cazorla O, Soulas-Sprauel P, Crozatier B, Morel E, Heymes C, Lezoualc'h F. Bisserier M, et al. Among authors: morel e. Circulation. 2015 Jan 27;131(4):390-400; discussion 400. doi: 10.1161/CIRCULATIONAHA.114.010686. Epub 2014 Nov 4. Circulation. 2015. PMID: 25369805
Epac in cardiac calcium signaling.
Ruiz-Hurtado G, Morel E, Domínguez-Rodríguez A, Llach A, Lezoualc'h F, Benitah JP, Gomez AM. Ruiz-Hurtado G, et al. Among authors: morel e. J Mol Cell Cardiol. 2013 May;58:162-71. doi: 10.1016/j.yjmcc.2012.11.021. Epub 2012 Dec 7. J Mol Cell Cardiol. 2013. PMID: 23220153 Review.
300 results